Point of Care Diagnostics Market to Reach US$ 70.89 Bn at a CAGR of 11.8% in 2027 | The Insight Partners

Point of Care Diagnostics Market to 2027 - Global Analysis and Forecasts By Product (Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Testing Products, Pregnancy and Fertility Testing Products, Coagulation Testing Products, Tumor/Cancer Marker Testing Products, Cholesterol Testing Products, Urinalysis Testing Products, Hematology Testing Products, Other POC Products), by Prescription Mode (Prescription-Based Testing, OTC Testing), End User (Professional Diagnostic Centers, Home Care, Research Laboratories, Others) and Geography

Publication Month: Aug 2019 | Report Code: TIPRE00006394 | No. of Pages: 202 | Category: Medical Device | Status: Published

The global point of care diagnostics market is US$ 26.60 Bn in 2018 and is predicted to grow at a CAGR of 11.8% during the forecast period 2019 – 2027, to reach US$ 70.89 Bn by 2027.

Asia Pacific is the fastest growing geographic market and is expected to be the significant revenue contributor in forecast period. The region has witnessed several technological advancements in the field of healthcare by the incorporation of point of care diagnostics for increasing the efficiency of treatments in the region. There is a growing interest of international players in China and India, government support in countries such as China, and advancing healthcare infrastructure. Therefore, the region has huge potential for the point of care diagnostics market players to grow during the forecast period.

 

Exhibit: Lucrative Regional Point of Care Diagnostics Markets

Market Insights

Increasing Incidences of Infectious Diseases

 

Point-of-care testing (POCT) plays critical roles in diagnosis, treatment, and prevention of infectious diseases. POC testing can be used to detect several major pathogens, including malarial parasites; human immunodeficiency virus (HIV); human papillomavirus (HPV); dengue, Ebola, and Zika viruses; and Mycobacterium tuberculosis (TB bacteria). HIV has infected over 40 million people worldwide; ~85% of this population resides in developing countries, which have a limited availability of clinical diagnostics and antiretroviral therapy (ART) monitoring platforms. To narrow down the diagnostic time, companies are developing POC test kits and reagents, for instance, Food and Drug Administration (FDA) has approved the ARCHITECT HIV Ag/Ab EIA, a fourth-generation assay, introduced by Abbott Laboratories. Increasing incidences of infectious diseases such as HIV is the major global public health issue. In 2018, World Health Organization (WHO) having claimed that more than 32 million HIV people are diagnosed, out of which 770 000 people died. At the end of 2018, 1.7 million people were reported to be newly infected globally, including 62% adults and 54% children. According to HIV and AIDS organization (AVERT), in 2018, 1.1 million US residents were infected with HIV, whereas APAC registered 5.2 million HIV-infected population. As per European Centre for Disease Prevention and Control, ~2 million people in Europe were infected with HIV in 2018. Such increase in the incidence of infectious diseases is expected to create a demand for point of care test kits across the world.

 

Product Launches and Product Developments

The number of point-of-care testing (POCT) has steadily increased over the last 40 years since it’s been widespread introduction. Growth of point of care market is likely to proceed with the help of the introduction of new products into the market, aimed at delivering inexpensive care at the facilities located at the closest-possible distances from the patients’ location. New technologies or products are being refined and improved to deliver easier to use devices with incremental improvements in analytical performance.

The growth of the POC market is mainly attributed to the introduction of new devices to perform molecular testing... Many new devices have been launched in recent years. For instance, in June 2019, Abbott launched first-ever rapid POC HbA1c test to aid in the diagnosis of diabetes; this test provides results in 3 minutes, enabling clinicians to develop informed, individualized care plans during patient consultation. Such advancements in new launched devices will propel the overall POC market growth during the forecast period.

Test Type Insights

The global point of care diagnostics market by product was led by glucose monitoring products segment. In 2018, the glucose monitoring products segment held a largest market share of the point of care diagnostics market. This segment is also expected to dominate the market in 2027 owing to the increasing diabetic patients. However, infectious disease testing product market is expected to grow at significant rate in the forecast period. Moreover, Infectious disease rapid test kits are widely available for a wide variety of prophlogistic pathogen targets, including bacterial, viral, fungal, protozoan, and other disease agents.

 

Exhibit: Point of Care Diagnostics Market, by Product



Strategic Insights

There have been limited developments made in the point of care diagnostics market during recent years. However, growth strategies such as approvals, collaborations, and partnerships have been witnessed in the market of point of care diagnostics. For instance, in February 2019, HemoCue AB, a subsidiary of Danaher, received US FDA 510(k) approval of the latest point-of-care hemoglobin test, the HemoCue Hb 801 System. Also, during January 2018, PTS Diagnostics, announced that they are releasing PTS Connect ProLink, a cloud-based biometric data collection and transfer software platform that helps retail partners’ pharmacies and clinics provide valuable health screening services to their customers.

 

POINT OF CARE DIAGNOSTICS – MARKET SEGMENTATION

 

BY PRODUCT

  • Glucose Monitoring
  • Infectious Disease Testing
    • HIV Testing Products
    • Influenza Testing Products
    • Sexually Transmitted Disease (STD) Testing Products
    • Hepatitis C Testing Products
    • Healthcare-Associated Infection (HAI) Testing Products
    • Tropical Disease Testing Products
    • Respiratory Infection Testing Products
    • Other Infectious Disease Testing Products
  • Cardiometabolic Testing
  • Pregnancy And Fertility Testing
  • Coagulation Testing
  • Tumor/Cancer Marker Testing
  • Cholesterol Testing
  • Urinalysis Testing
  • Hematology Testing
  • Other POC Products

 

BY PRESCRIPTION MODE

  • Prescription-Based Testing
  • OTC Testing

 

BY END USER

  • Professional Diagnostic Centers
  • Home Care
  • Research Laboratories
  • Others

 

BY GEOGRAPHY

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South and Central America
    • Brazil
    • Argentina

 

Company Profiles

 

  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Bio Rad Laboratories Inc.
  • Abbott
  • bioMérieux SA
  • Johnson & Johnson Services, Inc.
  • Nova Biomedical
  • Siemens AG
  • BD
  • PTS Diagnostics

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Point Of Care Diagnostics Market – By Product

1.3.2        Global Point Of Care Diagnostics Market – By Prescription Mode

1.3.3        Global Point Of Care Diagnostics Market – By End User

1.3.4        Global Point Of Care Diagnostics Market – By Geography

2.             Global Point Of Care Diagnostics Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Point of Care Diagnostics Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America PEST Analysis

4.2.2        Europe PEST Analysis

4.2.3        Asia Pacific PEST Analysis

4.2.4        Middle East & Africa PEST Analysis

4.2.5        South & Central America PEST Analysis

5.             Global Point of Care Diagnostics Market – Key Industry Dynamics

5.1       Key Market Drivers

5.1.1        Increasing Incidences of Infectious Diseases

5.1.2        Product Launches and Product Developments

5.1.3        Increasing Number of CLIA-waived POC tests

5.2       Key Market Restraints

5.2.1        Product Recalls in Market

5.3       Key Market Opportunities

5.3.1        Emerging Markets in Developing Countries

5.3.2        Increasing Number of Conferences and Events

5.4       Future Trends

5.4.1        Increasing Use of Home-Based POC Devices

5.5       Impact Analysis

6.             Point Of Care Diagnostics Market – Global Analysis

6.1       Global Point Of Care Diagnostics Market Revenue Forecasts And Analysis

6.2       Global Point Of Care Diagnostics Market, By Geography - Forecasts And Analysis

6.3       Performance of Key Players

7.             Global Point Of Care Diagnostics Market Analysis– by Product

7.1       Overview

7.2       Global Point of Care Diagnostics Market, By Product 2018 & 2027 (%)

7.3       Glucose Monitoring Products Market

7.3.1        Overview

7.3.2        Global Glucose Monitoring Products Market Revenue and Forecasts to 2027 (US$ Mn)

7.4       Infectious Disease Testing Market

7.4.1        Overview

7.4.2        Global Infectious Disease Testing Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.3        HIV Testing Products Market

7.4.3.1      Overview

7.4.3.2      Global HIV Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.4        Influenza Testing Products Market

7.4.4.1      Overview

7.4.4.2      Global Influenza Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.5        Sexually Transmitted Disease (STD) Testing Products Market

7.4.5.1      Overview

7.4.5.2      Global Sexually Transmitted Disease (STD) Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.6        Hepatitis C Testing Products Market

7.4.6.1      Overview

7.4.6.2      Global Hepatitis C Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.7        Healthcare-Associated Infection (HAI) Testing Products Market

7.4.7.1      Overview

7.4.7.2      Global Healthcare-Associated Infection (HAI) Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.8        Tropical Disease Testing Products Market

7.4.8.1      Overview

7.4.8.2      Global Tropical Disease Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.9        Respiratory Infection Testing Products Market

7.4.9.1      Overview

7.4.9.2      Global Respiratory Infection Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.10     Other Infectious Disease Products Market

7.4.10.1    Overview

7.4.10.2    Global Respiratory Infection Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

7.5       Cardiometabolic Testing Products Market

7.5.1        Overview

7.5.2        Global Cardiometabolic Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

7.6       Pregnancy And Fertility Testing Products Market

7.6.1        Overview

7.6.2        Global Pregnancy And Fertility Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

7.7       Coagulation Testing Products Market

7.7.1        Overview

7.7.2        Global Coagulation Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

7.8       Tumor/Cancer Marker Testing Products Market

7.8.1        Overview

7.8.2        Global Tumor/Cancer Marker Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

7.9       Cholesterol Testing Products Market

7.9.1        Overview

7.9.2        Global Cholesterol Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

7.10    Urinalysis Testing Products Market

7.10.1     Overview

7.10.2     Global Urinalysis Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

7.11    Haematology Testing Products Market

7.11.1     Overview

7.11.2     Global Haematology Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

7.12    Other POC Products Market

7.12.1     Overview

7.12.2     Global Other POC Market Revenue and Forecasts to 2027 (US$ Mn)

8.             Global Point Of Care Diagnostics Market Analysis– by Prescription Mode

8.1       Overview

8.2       Global Point of Care Diagnostics Market, By Prescription Mode 2018 & 2027 (%)

8.3       Prescription-Based Testing Market

8.3.1        Overview

8.3.2        Global Prescription-Based Testing Market Revenue and Forecasts to 2027 (US$ Mn)

8.4       OTC Testing Market

8.4.1.1      Overview

8.4.1.2      Global OTC Testing Market Revenue and Forecasts to 2027 (US$ Mn)

9.             Global Point Of Care Diagnostics Market Analysis– by End User

9.1       Overview

9.2       Global Point of Care Diagnostics Market, By End User 2018 & 2027 (%)

9.3       Professional Diagnostic Centers Market

9.3.1        Overview

9.3.2        Global Professional Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)

9.4       Home Care Market

9.4.1        Overview

9.4.2        Global Home Care Market Revenue and Forecasts to 2027 (US$ Mn)

9.5       Research Laboratories Market

9.5.1        Overview

9.5.2        Global Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

9.6       Others Market

9.6.1        Overview

9.6.2        Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

10.          Point of Care Diagnostics Market Revenue and Forecasts to 2027 – Geographical Analysis

10.1    North America Point of Care Diagnostics Market Revenue And Forecasts To 2027

10.1.1     North America Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.2     North America Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.2.1    North America Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.3     North America Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

10.1.4     North America Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.5     North America Point of Care Diagnostics Market Revenue and Forecasts to 2027, By Country (%)

10.1.6     US Point Of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.1    US Point Of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.2    US Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.6.2.1    US Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.6.3    US Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

10.1.6.4    US Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.7     Canada Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.1    Canada Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.2    Canada Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.7.2.1    Canada Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.7.3    Canada Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

10.1.7.4    Canada Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.8     Mexico Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.1    Mexico Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.2    Mexico Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.8.2.1    Mexico Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.8.3    Mexico Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

10.1.8.4    Mexico Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2    Europe Point of Care Diagnostics Market Revenue And Forecasts To 2027

10.2.1     Europe Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.2     Europe Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.2.1    Europe Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.3     Europe Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

10.2.4     Europe Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.5     Europe Point of care diagnostics Market Revenue and Forecasts to 2027, By Country (%)

10.2.6     UK Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.6.1    UK Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.6.2    UK Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.6.2.1    UK Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.6.3    UK Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

10.2.6.4    UK Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.7     Germany Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.7.1    Germany Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.7.2    Germany Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.7.2.1    Germany Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.7.3    Germany Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

10.2.7.4    Germany Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.8     France Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.8.1    France Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.8.2    France Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.8.2.1    France Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.8.3    France Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

10.2.8.4    France Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.9     Italy Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.9.1    Italy Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.9.2    Italy Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.9.2.1    Italy Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.9.3    Italy Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

10.2.9.4    Italy Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.10   Spain Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.10.1 Spain Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.10.2 Spain Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.10.2.1 Spain Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.10.3 Spain Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

10.2.10.4 Spain Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.          Asia Pacific POC Diagnostics Market Revenue and Forecasts to 2027

11.1    Asia Pacific Point of Care Diagnostics Market Revenue And Forecasts To 2027

11.2    Asia Pacific Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.1     Asia Pacific Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.1.1    Asia Pacific Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

11.2.2     Asia Pacific Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

11.2.3     Asia Pacific Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.4     Asia Pacific Point of Care Diagnostics Market Revenue and Forecasts to 2027, By Country (%)

11.2.5     Japan POC Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.5.1    Japan POC diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.5.2    Japan Point of Care Diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.5.2.1    Japan Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

11.2.5.3    Japan Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

11.2.5.4    Japan Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.6     China POC Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.6.1    China Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.6.2    China Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.6.2.1    China Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

11.2.6.3    China Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

11.2.6.4    China Point of Care Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.7     India Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.7.1    India Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.7.2    India Point of Care Diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.7.2.1    India Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

11.2.7.3    India Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

11.2.7.4    India Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.8     South Korea POC Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.8.1    South Korea Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.8.2    South Korea Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.8.2.1    South Korea Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

11.2.8.3    South Korea Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

11.2.8.4    South Korea Point of Care Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.9     Australia POC diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.9.1    Australia Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.9.2    Australia Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.9.2.1    Australia Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

11.2.9.3    Australia Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

11.2.9.4    Australia Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.          MEA

12.1    Middle East & Africa Point of care Diagnostics Market Revenue And Forecasts To 2027

12.1.1     Middle East & Africa Point of care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.1.2     Middle East & Africa Point of Care Diagnostics Market Revenue And Forecasts to 2027, By Product  (US$ Mn)

12.1.2.1    Middle East & Africa Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type  (US$ MN)

12.1.3     Middle East & Africa Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

12.1.4     Middle East & Africa Point of care diagnostics Market Revenue And Forecasts to 2027, By End User  (US$ Mn)

12.1.5     Middle East & Africa Point of care Diagnostics Market Revenue and Forecasts to 2027, By Country (%)

12.1.6     UAE Point of care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.1.6.1    UAE Point of care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.1.6.2    UAE Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

12.1.6.2.1    UAE Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

12.1.6.3    UAE Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

12.1.6.4    UAE Point of Care Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.1.7     Saudi Arabia Point of care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.1.7.1    Saudi Arabia Point of care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.1.7.2    Saudi Arabia Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

12.1.7.2.1    Saudi Arabia Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

12.1.7.3    Saudi Arabia Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

12.1.7.4    Saudi Arabia Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.1.8     South Africa Point of care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.1.8.1    South Africa Point of care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

12.1.8.2    South Africa Point of Care Diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

12.1.8.2.1    South Africa Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

12.1.8.3    South Africa Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

12.1.8.4    South Africa Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

13.          SCAM

13.1    South And Central America Point of care diagnostics Market Revenue And Forecasts To 2027

13.1.1     South and Central America Point of care diagnostics Market Revenue and Forecasts to 2027  (US$ Mn)

13.1.2     South and Central America Point of Care Diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

13.1.2.1    South and Central America Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

13.1.3     South and Central America Point of care diagnostics Market Revenue And Forecasts to 2027,  By Prescription Mode (US$ Mn)

13.1.4     South and Central America Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

13.1.5     South and Central America Point of care diagnostics Market Revenue and Forecasts to 2027, By Country (%)

13.1.6     Argentina Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

13.1.6.1    Argentina Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

13.1.6.2    Argentina Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

13.1.6.2.1    Argentina Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

13.1.6.3    Argentina Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

13.1.6.4    Argentina Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

13.1.7     Brazil Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

13.1.7.1    Brazil Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

13.1.7.2    Brazil Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

13.1.7.2.1    Brazil Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)

13.1.7.3    Brazil Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

13.1.7.4    Brazil Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

14.          Point of Care Diagnostics Market – Industry Landscape

14.1    Overview

14.2    Growth Strategies in the Point of care diagnostics market, 2016-2019

14.3    Organic Growth Strategies

14.3.1     Overview

14.3.2     Product Approval

14.3.3     Product Launch

14.3.4     Expansions

14.4    Inorganic Growth Strategies

14.4.1     Overview

14.4.2     Agreement

14.4.3     Acquisition

14.4.4     Partnership & Collaboration

15.          Point Of Care Diagnostics Market–Key Company Profiles

15.1    F. Hoffmann-La Roche Ltd.

15.1.1     Key Facts

15.1.2     Business Description

15.1.3     Financial Overview

15.1.4     Product Portfolio

15.1.5     SWOT Analysis

15.1.6     Key Developments

15.2    Abbott

15.2.1     Key Facts

15.2.2     Business Description

15.2.3     Financial Overview

15.2.4     Product Portfolio

15.2.5     SWOT Analysis

15.2.6     Key Developments

15.3    Siemens

15.3.1     Key Facts

15.3.2     Business Description

15.3.3     Financial Information

15.3.4     Product Portfolio

15.3.5     SWOT Analysis

15.3.6     Key Developments

15.4    BD

15.4.1     Key Facts

15.4.2     Business Description

15.4.3     Financial Information

15.4.4     Product Portfolio

15.4.5     SWOT Analysis

15.4.6     Key Developments

15.5    Polymer Technology Systems, Inc. (PTS DIAGNOSTICS)

15.5.1     Key Facts

15.5.2     Business Description

15.5.3     Financial Information

15.5.4     Product Portfolio

15.5.5     SWOT Analysis

15.5.6     Key Developments

15.6    Johnson & Johnson Services, Inc.

15.6.1     Key Facts

15.6.2     Business Description

15.6.3     Financial Overview

15.6.4     Product Portfolio

15.6.5     SWOT Analysis

15.6.6     Key Developments

15.7    Nova Biomedical

15.7.1     Key Facts

15.7.2     Business Description

15.7.3     Financial Overview

15.7.4     Product Portfolio

15.7.5     SWOT Analysis

15.7.6     Key Developments

15.8    bioMérieux SA

15.8.1     Key Facts

15.8.2     Business Description

15.8.3     Financial Information

15.8.4     Product Portfolio

15.8.5     SWOT Analysis

15.8.6     Key Developments

15.9    Bio-Rad Laboratories, Inc.

15.9.1     Key Facts

15.9.2     Business Description

15.9.3     Financial Information

15.9.4     Product Portfolio

15.9.5     SWOT Analysis

15.9.6     Key Developments

15.10 Danaher

15.10.1   Key Facts

15.10.2   Business Description

15.10.3   Financial Overview

15.10.4   Product Portfolio

15.10.5   SWOT Analysis

15.10.6   Key Developments

16.          Appendix

16.1    About The Insight Partners

16.2    Glossary Of Terms

LIST OF TABLES

Table 1.            North America Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 2.            North America Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 3.            North America Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode  (US$ Mn)

Table 4.            North America Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 5.            US Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 6.            US Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 7.            US Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 8.            US Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 9.            Canada Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 10.         Canada Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 11.         Canada Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 12.         Canada Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 13.         Mexico Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 14.         Mexico Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 15.         Mexico Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 16.         Mexico Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 17.         Europe Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 18.         Europe Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 19.         Europe Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 20.         Europe Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 21.         UK Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 22.         UK Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 23.         UK Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 24.         UK Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 25.         Germany Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 26.         Germany Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 27.         Germany Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 28.         Germany Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 29.         France Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 30.         France Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 31.         France Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 32.         France Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 33.         Italy Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 34.         Italy Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 35.         Italy Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 36.         Italy Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 37.         Spain Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 38.         Spain Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 39.         Spain Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 40.         Spain Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 41.         Asia Pacific Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 42.         Asia Pacific Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 43.         Asia Pacific Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 44.         Asia Pacific Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 45.         Japan Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 46.         Japan Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 47.         Japan Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 48.         Japan Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 49.         China Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 50.         China Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 51.         China Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 52.         China Point of Care Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 53.         India Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 54.         India Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 55.         India Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 56.         India Point of Care Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 57.         South Korea Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 58.         South Korea Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 59.         South Korea Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 60.         South Korea Point of Care Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 61.         Australia Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 62.         Australia Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 63.         Australia Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 64.         Australia Point of Care Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 65.         Middle East & Africa Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 66.         Middle East & Africa Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type  (US$ Mn)

Table 67.         Middle East & Africa Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 68.         Middle East & Africa Point of Care Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 69.         UAE Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 70.         UAE Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 71.         UAE Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 72.         UAE Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 73.         Saudi Arabia Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 74.         Saudi Arabia Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 75.         Saudi Arabia Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 76.         Saudi Arabia Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 77.         South Africa Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 78.         South Africa Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 79.         South Africa Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 80.         South Africa Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 81.         South and Central America Point of care diagnostics Market Revenue And Forecasts to 2027, By Product  (US$ Mn)

Table 82.         South and Central America Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 83.         South and Central America Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 84.         South and Central America Point of care diagnostics Market Revenue And Forecasts to 2027, By End User  (US$ Mn)

Table 85.         Argentina Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 86.         Argentina Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 87.         Argentina Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 88.         Argentina Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 89.         Brazil Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 90.         Brazil Infectious Disease Testing Products Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 91.         Brazil Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)

Table 92.         Brazil Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 93.         Recent Product approval in the Point of care diagnostics market

Table 94.         Recent Product launch in the Point of care diagnostics market

Table 95.         Recent Expansions in the Point of care diagnostics market

Table 96.         Agreement in the Point of care diagnostics market

Table 97.         Acquisitions in the Point of care diagnostics market

Table 98.         Partnership & Collaboration in the Point of care diagnostics market

Table 99.         Glossary of Terms, Point of Care Diagnostics Market

LIST OF FIGURES

Figure 1.          Point Of Care Diagnostic Market Segmentation

Figure 2.          Point Of Care Diagnostic Market Segmentation, by Region

Figure 3.          Asia Pacific Point of Care Diagnostics Market, Revenue (US$ Mn), By Geography 2018 & 2027

Figure 4.          Global Point of Care Diagnostics Market By Product, Market Share (%), 2018

Figure 5.          Global Point of Care Diagnostics Market By Prescription Mode, Market Share (%), 2018

Figure 6.          Global Point of Care Diagnostics Market By End User, Market Share (%), 2018

Figure 7.          North America : PEST Analysis

Figure 8.          Europe: PEST Analysis

Figure 9.          Asia - Pacific: PEST Analysis

Figure 10.       Middle East & Africa: PEST Analysis

Figure 11.       South & Central America: PEST Analysis

Figure 12.       Impact Analysis of Driver and Restraints Pertaining to Point of Care Diagnostics Market

Figure 13.       Global Point Of Care Diagnostics Market – Revenue Forecasts and Analysis – 2018- 2027

Figure 14.       Global Point of Care Diagnostics Market – by Geography Forecasts and Analysis – 2018- 2027

Figure 15.       Prominent Players in the Point of Care Diagnostics Market

Figure 16.       Global Point of Care Diagnostics Market, by Products 2018 & 2027 (%)

Figure 17.       Global Glucose Monitoring Products Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.       Global Infectious Disease Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.       Global HIV Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.       Global Influenza Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.       Global Sexually Transmitted Disease (STD) Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.       Global Hepatitis C Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.       Global Healthcare-Associated Infection (HAI) Testing Products Market Revenue and Forecasts to 2027  (US$ Mn)

Figure 24.       Global Tropical Disease Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.       Global Respiratory Infection Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.       Global Respiratory Infection Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.       Global Cardiometabolic Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 28.       Global Pregnancy And Fertility Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29.       Global Coagulation Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 30.       Global Tumor/Cancer Marker Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 31.       Global Cholesterol Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 32.       Global Urinalysis Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 33.       Global Haematology Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 34.       Global other POC Products Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 35.       Global Point of Care Diagnostics Market, by Prescription Mode 2018 & 2027 (%)

Figure 36.       Global Prescription-Based Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 37.       Global OTC Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 38.       Global Point of Care Diagnostics Market, by End User 2018 & 2027 (%)

Figure 39.       Global Professional Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 40.       Global Home Care Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 41.       Global Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 42.       Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 43.       North America Point Of Care Diagnostics Market Revenue Overview, by Country (2018) (US$ Mn)

Figure 44.       North America Point Of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 45.       North America Point of care diagnostics Market Revenue and Forecasts to 2027, By Country (%)

Figure 46.       US Point Of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 47.       Canada Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 48.       Mexico Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 49.       Europe Point of Care Diagnostics Market Overview, by Country (2018)

Figure 50.       Europe Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 51.       Europe Point of care diagnostics Market Revenue and Forecasts to 2027, By Country (%)

Figure 52.       UK Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 53.       Germany Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 54.       France Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 55.       Italy Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 56.       Spain Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 57.       Asia Pacific Point of Care Diagnostics Market Overview, by Country (2018)

Figure 58.       Asia Pacific Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 59.       Asia Pacific Point of Care Diagnostics Market Revenue and Forecasts to 2027, By Country (%)

Figure 60.       Japan Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 61.       China Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 62.       India Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 63.       South Korea Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 64.       Australia Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 65.       Middle East & Africa Point of care Diagnostics Market Revenue Overview, by Country, 2018 (US$ Mn)

Figure 66.       Middle East & Africa Point of care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 67.       Middle East & Africa Point of care Diagnostics Market Revenue and Forecasts to 2027, By Country (%)

Figure 68.       UAE Point of care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 69.       Saudi Arabia Point of care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 70.       South Africa Point of care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 71.       South and Central America Point of care diagnostics Market Revenue Overview, by Country, 2018 (US$ Mn)

Figure 72.       South and Central America Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 73.       South and Central America Point of care diagnostics Market Revenue and Forecasts to 2027, By Country (%)

Figure 74.       Argentina Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 75.       Brazil Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 76.       Growth Strategies in the Point of care diagnostics market, 2016-2019

Figure 77.       Organic Growth Strategies in the Point of care diagnostics market, 2016-2019

Figure 78.       Inorganic Growth Strategies in the Point of care diagnostics market, 2016-2019

The List of Companies

  1. F. Hoffmann-La Roche Ltd.
  2. Danaher Corporation
  3. Bio Rad Laboratories Inc.
  4. Abbott
  5. bioMérieux SA
  6. Johnson & Johnson Services, Inc.
  7. Nova Biomedical
  8. Siemens AG
  9. BD
  10. PTS Diagnostics
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the point of care diagnostics market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global point of care diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.